Investigation of RNA interference to suppress expression of full-length and fragment human huntingtin

NeuroMolecular Medicine

Volumn 9, Issue 2, 2007, Pages 145-155

  Gary, Devin S ^a,b   Davidson, Abigail ^b   Milhavet, Olivier ^c   Slunt, Hilda ^d   Borchelt, David R ^b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Full length Huntingtin; Huntington's disease; N terminal fragment; RNA interference; shRNA lentivirus

Indexed keywords

HUNTINGTIN; RNA; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL TYPE; CONTROLLED STUDY; EMBRYO; EXPRESSION VECTOR; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; RNA INTERFERENCE;

LENTIVIRUS;

EID: 34447553580     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02685888     Document Type: Article

References (23)

1. The Huntington's Disease Collaborative Research Group (1993) Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
2. Denovan-Wright E. M. and Davidson B. L. (2006) RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases. Gene Ther. 13, 525-531.
3. Devroe E. and Silver P. A. (2002) Retrovirus-delivered siRNA. BMC Biotechnol. 2, 15.
4. Dragatsis I., Efstratiadis A., and Zeitlin S. (1998) Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development 125, 1529-1539.
5. Dragatsis I., Levine M. S., and Zeitlin S. (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26, 300-306.
6. Elbashir S. M., Lendeckel W., and Tuschl T. (2001a) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188-200.
7. Elbashir S. M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. (2001b) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
8. Gitlin L., Karelsky S., and Andino R. (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418, 430-434.
9. Hammond S. M., Caudy A. A., and Hannon G. J. (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2, 110-119.
10. Harper S. Q., Staber P. D., He X., et al. (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820-5825.
11. Jacque J. M., Triques K., and Stevenson M. (2002) Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438.
12. Lassus P., Rodriguez J., and Lazebnik Y. (2002) Confirming specificity of RNAi in mammalian cells. Sci. STKE 2002, PL13.
13. Lewis D. L., Hagstrom J. E., Loomis A. G., Wolff J. A., and Herweijer H. (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32, 107-108.
14. Paddison P. J., Caudy A. A., Bernstein E., Hannon G. J., and Conklin D. S. (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958.
15. Rodriguez-Lebron E., Denovan-Wright E. M., Nash K., Lewin A. S., and Mandel R. J. (2005) Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618-633.
16. Schwarz D. S., Hutvagner G., Haley B., and Zamore P. D. (2002) Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell 10, 537-548.
17. Schwarz D. S., Ding H., Kennington L., et al. (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet. 2, 1307-1318.
18. Shaw G., Morse S., Ararat M., and Graham F. L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869-871.
19. Tobin A. J. and Signer E. R. (2000) Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10, 531-536.
20. Xia H., Mao Q., Paulson H. L., and Davidson B. L. (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20, 1006-1010.
21. Xia H., Mao Q., Eliason S. L., et al. (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10, 816-820.
22. Yamamoto A., Lucas J. J., and Hen R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66.
23. Yu J. Y., DeRuiter S. L., and Turner D. L. (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 6047-6052.